Autotaxin

Cellular and Molecular Life Sciences

Volumn 66, Issue 18, 2009, Pages 3009-3021

  Boutin, Jean A ^a   Ferry, Gilles ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Autotaxin; Cancer; Enzymatic assays; Lysophosphatidic acid; Lysophosphatidylcholine; Metastasis; NPP 2; Obesity

Indexed keywords

ENPP2 PROTEIN, HUMAN; ENZYME INHIBITOR; INORGANIC PYROPHOSPHATASE; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPID; MULTIENZYME COMPLEX; PHOSPHODIESTERASE I;

DRUG EFFECT; HUMAN; METASTASIS; NEOPLASM; OBESITY; PATHOLOGY; PHYSIOLOGY; REVIEW;

ENZYME INHIBITORS; HUMANS; LYSOPHOSPHOLIPIDS; MULTIENZYME COMPLEXES; NEOPLASM METASTASIS; NEOPLASMS; OBESITY; PHOSPHODIESTERASE I; PYROPHOSPHATASES;

EID: 77952594269     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-009-0056-9     Document Type: Review

References (134)

1. Prestwich GD, Gajewiak J, Zhang H, Xu X, Yang G, Serban M (2008) Phosphatase-resistant analogues of lysophosphatidic acid: agonists promote healing, antagonists and autotaxin inhibitors treat cancer. Biochim Biophys Acta 1781:588-594
2. Yuelling LM, Fuss B (2008) Autotaxin (ATX): a multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties. Biochim Biophys Acta 1781:525-530
3. Liotta LA, Mandler R, Murano G, Katz DA, Gordon RK, Chiang PK, Schiffmann E (1986) Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 83:3302-3306
4. Stracke ML, Krutzsch HC, Unsworth EJ, Arestad A, Cioce V, Schiffmann E, Liotta LA (1992) Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem 267:2524-2529
5. Liotta LA, Schiffmann E (1988) Tumour motility factors. Cancer Surv 7:631-652
6. Murata J, Lee HY, Clair T, Krutzsch HC, Arestad AA, Sobel ME, Liotta LA, Stracke ML (1994) cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases. J Biol Chem 269:30479-30484
7. Goding JW, Terkeltaub R, Maurice M, Deterre P, Sali A, Belli SI (1998) Ecto-phosphodiesterase/pyrophosphatase of lymphocytes and non-lymphoid cells: structure and function of the PC-1 family. Immunol Rev 161:11-26
8. Bollen M, Gijsbers R, Ceulemans H, Stalmans W, Stefan C (2000) Nucleotide pyrophosphatases/phosphodiesterases on the move. Crit Rev Biochem Mol Biol 35:393-432
9. Lee HY, Clair T, Mulvaney PT, Woodhouse EC, Aznavoorian S, Liotta LA, Stracke ML (1996) Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin. J Biol Chem 271:24408-24412
10. Kawagoe H, Stracke ML, Nakamura H, Sano K (1997) Expression and transcriptional regulation of the PD-Ialpha/ autotaxin gene in neuroblastoma. Cancer Res 57:2516-2521
11. Giganti A, Rodriguez M, Fould B, Moulharat N, Coge F, Chomarat P, Galizzi JP, Valet P, Saulnier-Blache JS, Boutin JA, Ferry G (2008) Murine and human autotaxin alpha, beta, and gamma isoforms: gene organization, tissue distribution, and biochemical characterization. J Biol Chem 283:7776-7789
12. Stracke ML, Clair T, Liotta LA (1997) Autotaxin, tumor motility-stimulating exophosphodiesterase. Adv Enzyme Regul 37:135-144
13. Nam SW, Clair T, Schiffmann E, Liotta LA, Stracke ML (2000) A sensitive screening assay for secreted motility-stimulating factors. Cell Motil Cytoskeleton 46:279-284
14. Clair T, Lee HY, Liotta LA, Stracke ML (1997) Autotaxin is an exoenzyme possessing 50-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities. J Biol Chem 272:996-1001
15. Clair T, Krutzsch HC, Liotta LA, Stracke ML (1997) Nucleotide binding to autotaxin: crosslinking of bound substrate followed by lysC digestion identifies two labeled peptides. Biochem Biophys Res Commun 236:449-454
16. Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K, Fukuzawa K (2002) Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem 277:39436-39442
17. Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB, Inoue K, Aoki J, Arai H (2002) Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 158:227-233
18. Ferry G, Tellier E, Try A, Gres S, Naime I, Simon MF, Rodriguez M, Boucher J, Tack I, Gesta S, Chomarat P, Dieu M, Raes M, Galizzi JP, Valet P, Boutin JA, Saulnier-Blache JS (2003) Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity. J Biol Chem 278:18162-18169
19. Valentine WJ, Fujiwara Y, Tsukahara R, Tigyi G (2008) Lysophospholipid signaling: beyond the EDGs. Biochim Biophys Acta 1780:597-605
20. Noguchi K, Herr D, Mutoh T, Chun J (2009) Lysophosphatidic acid (LPA) and its receptors. Curr Opin Pharmacol 9:15-23
21. Mutoh T, Chun J (2008) Lysophospholipid activation of G protein-coupled receptors. Subcell Biochem 49:269-297
22. Pamuklar Z, Federico L, Liu S, Umezu-Goto M, Dong A, Panchatcharam M, Fulkerson Z, Berdyshev E, Natarajan V, Fang F, van Meeteren LA, Moolenaar WH, Mills GB, Morris AJ, Smyth SS (2009) Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis. J Biol Chem 284(11):7385-7394
23. Jansen S, Stefan C, Creemers JW, Waelkens E, Van Eynde A, Stalmans W, Bollen M (2005) Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D. J Cell Sci 118:3081-3089
24. Koike S, Keino-Masu K, Ohto T, Masu M (2006) The N-terminal hydrophobic sequence of autotaxin (ENPP2) functions as a signal peptide. Genes Cells 11:133-142
25. Pradere JP, Tarnus E, Gres S, Valet P, Saulnier-Blache JS (2007) Secretion and lysophospholipase D activity of autotaxin by adipocytes are controlled by N-glycosylation and signal peptidase. Biochim Biophys Acta 1771:93-102
26. Stracke ML, Arestad A, Levine M, Krutzsch HC, Liotta LA (1995) Autotaxin is an N-linked glycoprotein but the sugar moieties are not needed for its stimulation of cellular motility. Melanoma Res 5:203-209
27. Haga A, Hashimoto K, Tanaka N, Nakamura KT, Deyashiki Y (2008) Scalable purification and characterization of the extracellular domain of human autotaxin from prokaryotic cells. Protein Expr Purif 59:9-17
28. Parrill AL (2005) Structural characteristics of lysophosphatidic acid biological targets. Biochem Soc Trans 33:1366-1369
29. Gijsbers R, Ceulemans H, Stalmans W, Bollen M (2001) Structural and catalytic similarities between nucleotide pyrophosphatases/ phosphodiesterases and alkaline phosphatases. J Biol Chem 276:1361-1368
30. Gijsbers R, Ceulemans H, Bollen M (2003) Functional characterization of the non-catalytic ectodomains of the nucleotide pyrophosphatase/ phosphodiesterase NPP1. Biochem J 371:321-330
31. Clair T, Aoki J, Koh E, Bandle RW, Nam SW, Ptaszynska MM, Mills GB, Schiffmann E, Liotta LA, Stracke ML (2003) Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res 63:5446-5453
32. Gijsbers R, Aoki J, Arai H, Bollen M (2003) The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site. FEBS Lett 538:60-64
33. Ferry G, Giganti A, Coge F, Bertaux F, Thiam K, Boutin JA (2007) Functional invalidation of the autotaxin gene by a single amino acid mutation in mouse is lethal. FEBS Lett 581:3572-3578
34. Cimpean A, Stefan C, Gijsbers R, Stalmans W, Bollen M (2004) Substrate-specifying determinants of the nucleotide pyrophosphatases/ phosphodiesterases NPP1 and NPP2. Biochem J 381:71-77
35. Koh E, Bandle RW, Roberts DD, Stracke ML, Clair T (2009) Novel point mutations attenuate autotaxin activity. Lipids Health Dis 8:4
36. Ferry G, Moulharat N, Pradere JP, Desos P, Try A, Genton A, Giganti A, Beucher-Gaudin M, Lonchampt M, Bertrand M, Saulnier-Blache JS, Tucker GC, Cordi A, Boutin JA (2008) S32826, a nanomolar inhibitor of autotaxin: discovery, synthesis and applications as a pharmacological tool. J Pharmacol Exp Ther 327:809-819
37. Lee HY, Murata J, Clair T, Polymeropoulos MH, Torres R, Manrow RE, Liotta LA, Stracke ML (1996) Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells. Biochem Biophys Res Commun 218:714-719
38. Koh E, Clair T, Woodhouse EC, Schiffmann E, Liotta L, Stracke M (2003) Site-directed mutations in the tumor-associated cytokine, autotaxin, eliminate nucleotide phosphodiesterase, lysophospholipase D, and motogenic activities. Cancer Res 63:2042-2045
39. van Meeteren LA, Ruurs P, Christodoulou E, Goding JW, Takakusa H, Kikuchi K, Perrakis A, Nagano T, Moolenaar WH (2005) Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate. J Biol Chem 280:21155-21161
40. Morishige J, Touchika K, Tanaka T, Satouchi K, Fukuzawa K, Tokumura A (2007) Production of bioactive lysophosphatidic acid by lysophospholipase D in hen egg white. Biochim Biophys Acta 1771:491-499
41. Wykle RL, Kraemer WF, Schremmer JM (1977) Studies of lysophospholipase D of rat liver and other tissues. Arch Biochem Biophys 184:149-155
42. Sugimoto S, Sugimoto H, Aoyama C, Aso C, Mori M, Izumi T (2006) Purification and characterization of lysophospholipase D from rat brain. Biochim Biophys Acta 1761:1410-1418
43. Lee J, Jung ID, Nam SW, Clair T, Jeong EM, Hong SY, Han JW, Lee HW, Stracke ML, Lee HY (2001) Enzymatic activation of autotaxin by divalent cations without EF-hand loop region involvement. Biochem Pharmacol 62:219-224
44. Wykle RL, Schremmer JM (1974) A lysophospholipase D pathway in the metabolism of ether-linked lipids in brain microsomes. J Biol Chem 249:1742-1746
45. Kawasaki T, Snyder F (1987) The metabolism of lyso-plateletactivating factor (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by a calcium-dependent lysophospholipase D in rabbit kidney medulla. Biochim Biophys Acta 920:85-93
46. Tokumura A, Miyake M, Yoshimoto O, Shimizu M, Fukuzawa K (1998) Metal-ion stimulation and inhibition of lysophospholipase D which generates bioactive lysophosphatidic acid in rat plasma. Lipids 33:1009-1015
47. Gesta S, Simon MF, Rey A, Sibrac D, Girard A, Lafontan M, Valet P, Saulnier-Blache JS (2002) Secretion of a lysophospholipase D activity by adipocytes: involvement in lysophosphatidic acid synthesis. J Lipid Res 43:904-910
48. Belli SI, Sali A, Goding JW (1994) Divalent cations stabilize the conformation of plasma cell membrane glycoprotein PC-1 (alkaline phosphodiesterase I). Biochem J 304(Pt 1):75-80
49. Xie Y, Meier KE (2004) Lysophospholipase D and its role in LPA production. Cell Signal 16:975-981
50. Ferguson CG, Bigman CS, Richardson RD, van Meeteren LA, Moolenaar WH, Prestwich GD (2006) Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity. Org Lett 8:2023-2026
51. Takakusa H, Kikuchi K, Urano Y, Sakamoto S, Yamaguchi K, Nagano T (2002) Design and synthesis of an enzyme-cleavable sensor molecule for phosphodiesterase activity based on fluorescence resonance energy transfer. J Am Chem Soc 124:1653-1657
52. Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, Aoki J, Hama K, Okudaira S, Tanaka M, Tomiya T, Yanase M, Tejima K, Nishikawa T, Arai M, Arai H, Omata M, Fujiwara K, Yatomi Y (2007) Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C. J Clin Gastroenterol 41:616-623
53. Nakamura K, Igarashi K, Ide K, Ohkawa R, Okubo S, Yokota H, Masuda A, Oshima N, Takeuchi T, Nangaku M, Okudaira S, Arai H, Ikeda H, Aoki J, Yatomi Y (2008) Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. Clin Chim Acta 388:51-58
54. Nakamura K, Kishimoto T, Ohkawa R, Okubo S, Tozuka M, Yokota H, Ikeda H, Ohshima N, Mizuno K, Yatomi Y (2007) Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids. Anal Biochem 367:20-27
55. Boucharaba A, Serre CM, Gres S, Saulnier-Blache JS, Bordet JC, Guglielmi J, Clezardin P, Peyruchaud O (2004) Plateletderived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J Clin Invest 114:1714-1725
56. van Meeteren LA, Ruurs P, Stortelers C, Bouwman P, van Rooijen MA, Pradere JP, Pettit TR, Wakelam MJ, Saulnier-Blache JS, Mummery CL, Moolenaar WH, Jonkers J (2006) Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol Cell Biol 26:5015-5022
57. Mazereeuw-Hautier J, Gres S, Fanguin M, Cariven C, Fauvel J, Perret B, Chap H, Salles JP, Saulnier-Blache JS (2005) Production of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activity. J Invest Dermatol 125:421-427
58. Hammack BN, Fung KY, Hunsucker SW, Duncan MW, Burgoon MP, Owens GP, Gilden DH (2004) Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult Scler 10:245-260
59. Sato K, Malchinkhuu E, Muraki T, Ishikawa K, Hayashi K, Tosaka M, Mochiduki A, Inoue K, Tomura H, Mogi C, Nochi H, Tamoto K, Okajima F (2005) Identification of autotaxin as a neurite retraction-inducing factor of PC12 cells in cerebrospinal fluid and its possible sources. J Neurochem 92:904-914
60. Tokumura A, Kume T, Fukuzawa K, Tahara M, Tasaka K, Aoki J, Arai H, Yasuda K, Kanzaki H (2007) Peritoneal fluids from patients with certain gynecologic tumor contain elevated levels of bioactive lysophospholipase D activity. Life Sci 80:1641-1649
61. Masuda A, Nakamura K, Izutsu K, Igarashi K, Ohkawa R, Jona M, Higashi K, Yokota H, Okudaira S, Kishimoto T, Watanabe T, Koike Y, Ikeda H, Kozai Y, Kurokawa M, Aoki J, Yatomi Y (2008) Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma. Br J Haematol 143:60-70
62. Nakamura K, Nangaku M, Ohkawa R, Okubo S, Yokota H, Ikeda H, Aoki J, Yatomi Y (2008) Analysis of serum and urinary lysophospholipase D/autotaxin in nephrotic syndrome. Clin Chem Lab Med 46:150-151
63. Nochi H, Tomura H, Tobo M, Tanaka N, Sato K, Shinozaki T, Kobayashi T, Takagishi K, Ohta H, Okajima F, Tamoto K (2008) Stimulatory role of lysophosphatidic acid in cyclooxygenase-2 induction by synovial fluid of patients with rheumatoid arthritis in fibroblast-like synovial cells. J Immunol 181:5111-5119
64. Aoki J, Inoue A, Okudaira S (2008) Two pathways for lysophosphatidic acid production. Biochim Biophys Acta 1781:513-518
65. Nakamura K, Ohkawa R, Okubo S, Tozuka M, Okada M, Aoki S, Aoki J, Arai H, Ikeda H, Yatomi Y (2007) Measurement of lysophospholipase D/autotaxin activity in human serum samples. Clin Biochem 40:274-277
66. Ohuchi H, Hayashibara Y, Matsuda H, Onoi M, Mitsumori M, Tanaka M, Aoki J, Arai H, Noji S (2007) Diversified expression patterns of autotaxin, a gene for phospholipid-generating enzyme during mouse and chicken development. Dev Dyn 236:1134-1143
67. Bachner D, Ahrens M, Betat N, Schroder D, Gross G (1999) Developmental expression analysis of murine autotaxin (ATX). Mech Dev 84:121-125
68. Liszewska E, Reinaud P, Billon-Denis E, Dubois O, Robin P, Charpigny G (2009) Lysophosphatidic acid signaling during embryo development in sheep: involvement in prostaglandin synthesis. Endocrinology 150:422-434
69. Tice DA, Szeto W, Soloviev I, Rubinfeld B, Fong SE, Dugger DL, Winer J, Williams PM, Wieand D, Smith V, Schwall RH, Pennica D, Polakis P (2002) Synergistic induction of tumor antigens by Wnt-1 signaling and retinoic acid revealed by gene expression profiling. J Biol Chem 277:14329-14335
70. Kenny PA, Enver T, Ashworth A (2005) Receptor and secreted targets of Wnt-1/beta-catenin signalling in mouse mammary epithelial cells. BMC Cancer 5:3
71. Bachner D, Ahrens M, Schroder D, Hoffmann A, Lauber J, Betat N, Steinert P, Flohe L, Gross G (1998) Bmp-2 downstream targets in mesenchymal development identified by subtractive cloning from recombinant mesenchymal progenitors (C3H10T1/ 2). Dev Dyn 213:398-411
72. Johnson K, Hashimoto S, Lotz M, Pritzker K, Goding J, Terkeltaub R (2001) Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification. Arthritis Rheum 44:1071-1081
73. Kehlen A, Lauterbach R, Santos AN, Thiele K, Kabisch U, Weber E, Riemann D, Langner J (2001) IL-1 beta- and IL-4- induced down-regulation of autotaxin mRNA and PC-1 in fibroblast-like synoviocytes of patients with rheumatoid arthritis (RA). Clin Exp Immunol 123:147-154
74. Kanda H, Newton R, Klein R, Morita Y, Gunn MD, Rosen SD (2008) Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat Immunol 9:415-423
75. Nakasaki T, Tanaka T, Okudaira S, Hirosawa M, Umemoto E, Otani K, Jin S, Bai Z, Hayasaka H, Fukui Y, Aozasa K, Fujita N, Tsuruo T, Ozono K, Aoki J, Miyasaka M (2008) Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte- endothelial cell interactions. Am J Pathol 173:1566-1576
76. Khurana S, Tomar A, George SP, Wang Y, Siddiqui MR, Guo H, Tigyi G, Mathew S (2008) Autotaxin and lysophosphatidic acid stimulate intestinal cell motility by redistribution of the actin modifying protein villin to the developing lamellipodia. Exp Cell Res 314:530-542
77. Rogers MS, Rohan RM, Birsner AE, D'Amato RJ (2004) Genetic loci that control the angiogenic response to basic fibroblast growth factor. FASEB J 18:1050-1059
78. Boucher J, Quilliot D, Praderes JP, Simon MF, Gres S, Guigne C, Prevot D, Ferry G, Boutin JA, Carpene C, Valet P, Saulnier- Blache JS (2005) Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression. Diabetologia 48:569-577
79. Inoue M, Ma L, Aoki J, Ueda H (2008) Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain. J Neurochem 107:1556-1565
80. Inoue M, Xie W, Matsushita Y, Chun J, Aoki J, Ueda H (2008) Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid. Neuroscience 152:296-298
81. Inoue M, Ma L, Aoki J, Chun J, Ueda H (2008) Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain. Mol Pain 4:6
82. Dennis J, Nogaroli L, Fuss B (2005) Phosphodiesterase-Ialpha/ autotaxin (PD-Ialpha/ATX): a multifunctional protein involved in central nervous system development and disease. J Neurosci Res 82:737-742
83. Fuss B, Baba H, Phan T, Tuohy VK, Macklin WB (1997) Phosphodiesterase I, a novel adhesion molecule and/or cytokine involved in oligodendrocyte function. J Neurosci 17:9095-9103
84. Dennis J, White MA, Forrest AD, Yuelling LM, Nogaroli L, Afshari FS, Fox MA, Fuss B (2008) Phosphodiesterase-Ialpha/ autotaxin's MORFO domain regulates oligodendroglial process network formation and focal adhesion organization. Mol Cell Neurosci 37:412-424
85. Fox MA, Alexander JK, Afshari FS, Colello RJ, Fuss B (2004) Phosphodiesterase-I alpha/autotaxin controls cytoskeletal organization and FAK phosphorylation during myelination. Mol Cell Neurosci 27:140-150
86. Fox MA, Colello RJ, Macklin WB, Fuss B (2003) Phosphodiesterase- Ialpha/autotaxin: a counteradhesive protein expressed by oligodendrocytes during onset of myelination. Mol Cell Neurosci 23:507-519
87. Nam SW, Clair T, Campo CK, Lee HY, Liotta LA, Stracke ML (2000) Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells. Oncogene 19:241-247
88. Nam SW, Clair T, Kim YS, McMarlin A, Schiffmann E, Liotta LA, Stracke ML (2001) Autotaxin (NPP-2), a metastasisenhancing motogen, is an angiogenic factor. Cancer Res 61:6938-6944
89. Black EJ, Clair T, Delrow J, Neiman P, Gillespie DA (2004) Microarray analysis identifies autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun. Oncogene 23:2357-2366
90. Wolter S, Mushinski JF, Saboori AM, Resch K, Kracht M (2002) Inducible expression of a constitutively active mutant of mitogen-activated protein kinase kinase 7 specifically activates c-JUN NH2-terminal protein kinase, alters expression of at least nine genes, and inhibits cell proliferation. J Biol Chem 277:3576-3584
91. Li S, Zhang J (2009) Lipopolysaccharide induces autotaxin expression in human monocytic THP-1 cells. Biochem Biophys Res Commun 378:264-268
92. Wang W, Wu F, Fang F, Tao Y, Yang L (2008) Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo. Clin Cancer Res 14:6804-6812
93. Todorova MG, Fuentes E, Soria B, Nadal A, Quesada I (2009) Lysophosphatidic acid induces Ca2+ mobilization and c-Myc expression in mouse embryonic stem cells via the phospholipase C pathway. Cell Signal 21:523-528
94. Dufner-Beattie J, Lemons RS, Thorburn A (2001) Retinoic acidinduced expression of autotaxin in N-myc-amplified neuroblastoma cells. Mol Carcinog 30:181-189
95. Taghavi P, Verhoeven E, Jacobs JJ, Lambooij JP, Stortelers C, Tanger E, Moolenaar WH, van Lohuizen M (2008) In vitro genetic screen identifies a cooperative role for LPA signaling and c-Myc in cell transformation. Oncogene 27:6806-6816
96. Huang RY, Wang SM, Hsieh CY, Wu JC (2008) Lysophosphatidic acid induces ovarian cancer cell dispersal by activating Fyn kinase associated with p120-catenin. Int J Cancer 123:801-809
97. Chen M, O'Connor KL (2005) Integrin alpha6beta4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells. Oncogene 24:5125-5130
98. Song J, Jie C, Polk P, Shridhar R, Clair T, Zhang J, Yin L, Keppler D (2006) The candidate tumor suppressor CST6 alters the gene expression profile of human breast carcinoma cells: down-regulation of the potent mitogenic, motogenic, and angiogenic factor autotaxin. Biochem Biophys Res Commun 340:175-182
99. Lee J, Duk JI, Gyo PC, Han JW, Young LH (2006) Autotaxin stimulates urokinase-type plasminogen activator expression through phosphoinositide 3-kinase-Akt-nuclear [corrected] factor kappa B signaling cascade in human melanoma cells. Melanoma Res 16:445-452
100. Quinones LG, Garcia-Castro I (2004) Characterization of human melanoma cell lines according to their migratory properties in vitro. In Vitro Cell Dev Biol Anim 40:35-42
101. Kishi Y, Okudaira S, Tanaka M, Hama K, Shida D, Kitayama J, Yamori T, Aoki J, Fujimaki T, Arai H (2006) Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. J Biol Chem 281:17492-17500
102. Kehlen A, Englert N, Seifert A, Klonisch T, Dralle H, Langner J, Hoang-Vu C (2004) Expression, regulation and function of autotaxin in thyroid carcinomas. Int J Cancer 109:833-838
103. Ptaszynska MM, Pendrak ML, Bandle RW, Stracke ML, Roberts DD (2008) Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells. Mol Cancer Res 6:352-363
104. Billon-Denis E, Tanfin Z, Robin P (2008) Role of lysophosphatidic acid in the regulation of uterine leiomyoma cell proliferation by phospholipase D and autotaxin. J Lipid Res 49:295-307
105. Zeng Y, Kakehi Y, Nouh MA, Tsunemori H, Sugimoto M, Wu XX (2009) Gene expression profiles of lysophosphatidic acidrelated molecules in the prostate: relevance to prostate cancer and benign hyperplasia. Prostate 69:283-292
106. Singh AD, Sisley K, Xu Y, Li J, Faber P, Plummer SJ, Mudhar HS, Rennie IG, Kessler PM, Casey G, Williams BG (2007) Reduced expression of autotaxin predicts survival in uveal melanoma. Br J Ophthalmol 91:1385-1392
107. Cooper AB, Wu J, Lu D, Maluccio MA (2007) Is autotaxin (ENPP2) the link between hepatitis C and hepatocellular cancer? J Gastrointest Surg 11:1628-1634
108. Baumforth KR, Flavell JR, Reynolds GM, Davies G, Pettit TR, Wei W, Morgan S, Stankovic T, Kishi Y, Arai H, Nowakova M, Pratt G, Aoki J, Wakelam MJ, Young LS, Murray PG (2005) Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells. Blood 106:2138-2146
109. Steeg PS (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12:895-904
110. Yang Y, Mou L, Liu N, Tsao MS (1999) Autotaxin expression in non-small-cell lung cancer. Am J Respir Cell Mol Biol 21:216-222
111. Euer N, Schwirzke M, Evtimova V, Burtscher H, Jarsch M, Tarin D, Weidle UH (2002) Identification of genes associated with metastasis of mammary carcinoma in metastatic versus non-metastatic cell lines. Anticancer Res 22:733-740
112. Yang SY, Lee J, Park CG, Kim S, Hong S, Chung HC, Min SK, Han JW, Lee HW, Lee HY (2002) Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells. Clin Exp Metastasis 19:603-608
113. Stassar MJ, Devitt G, Brosius M, Rinnab L, Prang J, Schradin T, Simon J, Petersen S, Kopp-Schneider A, Zoller M (2001) Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br J Cancer 85:1372-1382
114. Zhao Z, Xu S, Zhang G (1999) A study on expression of autotaxin mRNA in hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi 7:140-141
115. Zhang G, Zhao Z, Xu S, Ni L, Wang X (1999) Expression of autotaxin mRNA in human hepatocellular carcinoma. Chin Med J (Engl) 112:330-332
116. Ioannidis JP, Allison DB, Ball CA, Coulibaly I, Cui X, Culhane AC, Falchi M, Furlanello C, Game L, Jurman G, Mangion J, Mehta T, Nitzberg M, Page GP, Petretto E, van Noort V (2009) Repeatability of published microarray gene expression analyses. Nat Genet 41:149-155
117. Kawagoe H, Soma O, Goji J, Nishimura N, Narita M, Inazawa J, Nakamura H, SanoK(1995) Molecular cloning and chromosomal assignment of the human brain-type phosphodiesterase I/nucleotide pyrophosphatase gene (PDNP2). Genomics 30:380-384
118. Klominek J, Robert KH, Bergh J, Hjerpe A, Gahrton G, Sundqvist KG (1998) Production of a motility factor by a newly established lung adenocarcinoma cell line. Anticancer Res 18:759-767
119. Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, McDonough WS, Sloan A, Coons SW, Berens ME (2005) Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 7:7-16
120. Tanaka M, Okudaira S, Kishi Y, Ohkawa R, Iseki S, Ota M, Noji S, Yatomi Y, Aoki J, Arai H (2006) Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J Biol Chem 281:25822-25830
121. van Meeteren LA, Moolenaar WH (2007) Regulation and biological activities of the autotaxin-LPA axis. Prog Lipid Res 46:145-160
122. Clair T, Koh E, Ptaszynska M, Bandle RW, Liotta LA, Schiffmann E, Stracke ML (2005) L-Histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxin. Lipids Health Dis 4:5
123. Gendaszewska-Darmach E (2008) Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promising targets in therapies of cancer and other diseases. Acta Biochim Pol 55:227-240
124. Tsuda S, Okudaira S, Moriya-Ito K, Shimamoto C, Tanaka M, Aoki J, Arai H, Murakami-Murofushi K, Kobayashi T (2006) Cyclic phosphatidic acid is produced by autotaxin in blood. J Biol Chem 281:26081-26088
125. Kano K, Arima N, Ohgami M, Aoki J (2008) LPA and its analogs-attractive tools for elucidation of LPA biology and drug development. Curr Med Chem 15:2122-2131
126. Federico L, Pamuklar Z, Smyth SS, Morris AJ (2008) Therapeutic potential of autotaxin/lysophospholipase d inhibitors. Curr Drug Targets 9:698-708
127. Baker DL, Fujiwara Y, Pigg KR, Tsukahara R, Kobayashi S, Murofushi H, Uchiyama A, Murakami-Murofushi K, Koh E, Bandle RW, Byun HS, Bittman R, Fan D, Murph M, Mills GB, Tigyi G (2006) Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis. J Biol Chem 281:22786-22793
128. van Meeteren LA, Brinkmann V, Saulnier-Blache JS, Lynch KR, Moolenaar WH (2008) Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasisenhancing and angiogenic lysophospholipase D. Cancer Lett 266:203-208
129. Moulharat N, Fould B, Giganti A, Boutin JA, Ferry G (2008) Molecular pharmacology of adipocyte-secreted autotaxin. Chem Biol Interact 172:115-124
130. Parrill AL, Echols U, Nguyen T, Pham TC, Hoeglund A, Baker DL (2008) Virtual screening approaches for the identification of non-lipid autotaxin inhibitors. Bioorg Med Chem 16:1784-1795
131. Saunders LP, Ouellette A, Bandle R, Chang WC, Zhou H, Misra RN, De La Cruz EM, Braddock DT (2008) Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion. Mol Cancer Ther 7:3352-3362
132. Samadi N, Gaetano C, Goping IS, Brindley DN (2009) Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis. Oncogene 28:1028-1039
133. Satoh Y, Ohkawa R, Nakamura K, Higashi K, Kaneko M, Yokota H, Aoki J, Arai H, Yuasa Y, Yatomi Y (2007) Lysophosphatidic acid protection against apoptosis in the human pre- B-cell line Nalm-6. Eur J Haematol 78:510-517
134. Shankavaram UT, Reinhold WC, Nishizuka S, Major S, Morita D, Chary KK, Reimers MA, Scherf U, Kahn A, Dolginow D, Cossman J, Kaldjian EP, Scudiero DA, Petricoin E, Liotta L, Lee JK, Weinstein JN (2007) Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol Cancer Ther 6:820-832